Owlet™ Secures CDSCO Approval for Dream Sock® and Plans 2026 Expansion into India

Core Insights - Owlet, Inc. has received approval from the Central Drugs Standard Control Organization (CDSCO) for its Dream Sock® product, enabling the company to distribute its integrated monitoring devices in India [1] Group 1: Company Developments - The approval from CDSCO is a significant milestone for Owlet, Inc. as it prepares to launch its products in India [1] - The company plans to introduce its integrated monitoring devices, including Dream Sock®, Dream Sight™, and Dream Duo™, in early 2026 [1] Group 2: Regulatory Approval - The CDSCO is India's national regulatory body, and its approval is crucial for Owlet's market entry [1]